congenital erythropoietic porphyria (CEP, Gunther's disease)
Jump to navigation
Jump to search
Epidemiology
rare
Pathology
- red urine is a result of excretion of coproporphyrin I & uroporphyrinogen I
- deficiency in uroporphyrinogen III cosynthase (UROS) results in non-enzymatic conversion of hydroxymethylbilane into uroporphyrinogen I
Genetics
- autosomal recessive
- associated with defects in UROS
Clinical manifestations
- heterogeneous, ranging from nonimmune hydrops fetalis due to severe hemolytic anemia in utero to milder, later onset forms, which have only skin lesions due to cutaneous photosensitivity in adult life
- generally manifests shortly after birth
- red-pigmented urine
- erythrodontia (red-stained teeth)
- hemolytic anemia
- skin lesions may be severely mutilating
- severe cutaneous photosensitivity
- blisters
- scarring alopecia
- hirsuitism
- splenomegaly & early demise occur
* images[4]
More general terms
Additional terms
- coproporphyrinogen I
- heme synthesis
- uroporphyrinogen I
- uroporphyrinogen-III synthase; UROIIIS; UROS; hydroxymethylbilane hydrolyase [cyclizing]; uroporphyrinogen-III cosynthase (UROS)
References
- ↑ Textbook of Biochemistry with Clinical Correlations, 3rd ed., TM Devlin (ed), Wiley-Liss, NY 1992 pg 1012
- ↑ Clinical Diagnosis & Management by Laboratory Methods, 19th edition, J.B. Henry (ed), W.B. Saunders Co., Philadelphia, PA. 1996, pg 172
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 179
- ↑ 4.0 4.1 Hsiao YW, Chiou TJ, Huang YC Late-Onset Congenital Erythropoietic Porphyria. JAMA Dermatol. Published online December 29, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34964809 https://jamanetwork.com/journals/jamadermatology/fullarticle/2787676